V-Nova completes the acquisition of Parallaxter Srl, the company behind the PresenZ XR technology
29.11.2023 12:00:00 EET | Business Wire | Press release
V-Nova, a leading provider of data compression solutions, announces the full acquisition of Parallaxter Srl, completing its prior investments in the company and incorporating it into the V-Nova group. Parallaxter are the XR experts behind the PresenZ technology and this acquisition will greatly expand V-Nova’s portfolio of IP and technologies in VR/XR and gaming, as well as further strengthen its position in the data and video compression industry.
V-Nova PresenZ, a Lumiere Award winning format that combines Parallaxter's PresenZ technology and V-Nova's point-cloud compression, is set to revolutionize storytelling in VR. It offers users cinematic photorealism and 6DoF for real-time navigation in pre-rendered scenes, breaking free from static viewpoints and ensuring full immersiveness. V-Nova PresenZ is distributed at scale also to stand-alone XR devices thanks to MPEG-5 LCEVC enhanced pixel streaming.
The format dovetails with standard Computer Graphics and Special FX production workflows, significantly cutting content production costs, and it also allows for the re-mastering of existing asset libraries. Additionally, it supports the integration of pre-rendered photorealistic assets with real-time-rendered interactive elements and after-effects, opening new possibilities for interactive immersion.
"We are thrilled to welcome our partner Parallaxter and its PresenZ technology to the V-Nova family," said Guido Meardi, CEO of V-Nova. “The new combined format is set to redefine digital entertainment, offering fully immersive, lifelike experiences with six degrees of freedom (6DoF) that revolutionize traditional visual storytelling. Collaborating with top studios on several productions, we're gearing up to introduce this groundbreaking experience to consumers shortly. Our aim is to bring the future of digital entertainment to life, opening new horizons in how stories are told and experienced.”
"We are excited to join forces with V-Nova," said Tristan Salome, CEO of Parallaxter. “V-Nova’s data compression technology and Parallaxter’s unique solution for volumetric immersion are complementary technologies that will enable us to push the boundaries of immersive visuals and deliver higher quality digital experiences at scale. Imagine being immersed in Hollywood-grade CGI, experiencing lifelike parallax, occlusions, reflections, and textures, at full display frame rate."
Eubelius CVBA advised on the transaction.
About V-Nova
V-Nova is committed to unlocking higher quality digital experiences at scale. Its technologies, including MPEG-5 LCEVC and VC-6, are based on the innovative use of AI and parallel processing, improve data, video, imaging, and point-cloud compression, and have been granted international standard status by MPEG, ISO and SMPTE. V-Nova’s relentless investment in R&D has built a portfolio of over 900 international patents, along with a range of software products and solutions. More about V-Nova: www.v-nova.com
About Parallaxter
Parallaxter SRL, founded in 2014, is a Belgian XR software company that developed and patented PresenZ, the revolutionary Volumetric Movie point cloud format. It allows the viewer to experience unprecedented immersion comfort compared to "standard" 360-degree movies and unprecedented offline ray-tracing visual fidelity compared to real-time rendering. The viewer truly feels like being inside the movie, thanks to its six degrees of freedom approach that creates a ‘cloud’ of data points where the viewer is free to move.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231129420904/en/
Contact information
V-Nova Investor Relations: Antonio Filippi, CFO – investor.relations@v-nova.com
V-Nova Marketing Communications: Joao Felix – press@v-nova.com
Bubble UK & EMEA PR Account Director: Danielle Harper – danielleh@bubbleagency.com
Bubble Head of Americas: Kim Willsher – Kimw@bubbleagency.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom